These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 1874879)
1. Simple and rapid micro-analytical procedures for the estimation of milacemide and its metabolite glycinamide in rat plasma and cerebrospinal fluid by high-performance liquid chromatography. Semba J; Ratnaraj N; Patsalos PN J Chromatogr; 1991 Apr; 565(1-2):357-62. PubMed ID: 1874879 [TBL] [Abstract][Full Text] [Related]
2. Antiepileptic drug pharmacokinetics and neuropharmacokinetics in individual rats by repetitive withdrawal of blood and cerebrospinal fluid: milacemide. Semba J; Curzon G; Patsalos PN Br J Pharmacol; 1993 Apr; 108(4):1117-24. PubMed ID: 8485621 [TBL] [Abstract][Full Text] [Related]
3. Is the oxidation of milacemide by monoamine oxidase a major factor in its anticonvulsant actions? O'Brien EM; Tipton KF; Strolin Benedetti M; Bonsignori A; Marrari P; Dostert P Biochem Pharmacol; 1991 Jun; 41(11):1731-7. PubMed ID: 2043162 [TBL] [Abstract][Full Text] [Related]
4. Microionophoretic study with milacemide, a glycine precursor, on mammalian central nervous system cells. Godfraind JM Br J Pharmacol; 1990 May; 100(1):119-25. PubMed ID: 2196964 [TBL] [Abstract][Full Text] [Related]
5. Determination of the monoamine oxidase B inhibitor Ro 19-6327 in plasma by high-performance liquid chromatography using precolumn derivatization with fluorescamine and fluorescence detection. Wyss R; Philipp W J Chromatogr; 1990 May; 507():187-98. PubMed ID: 2380287 [TBL] [Abstract][Full Text] [Related]
6. Does FAD-dependent polyamine oxidase contribute to the metabolism of milacemide? Strolin Benedetti M; Cocchiara G; Colombo M; Dostert P J Neural Transm Suppl; 1990; 32():351-6. PubMed ID: 2128509 [TBL] [Abstract][Full Text] [Related]
7. The interactions of milacemide with monoamine oxidase. O'Brien EM; Tipton KF; McCrodden JM; Youdim MB Biochem Pharmacol; 1994 Feb; 47(4):617-23. PubMed ID: 8129740 [TBL] [Abstract][Full Text] [Related]
8. MAO activity, metabolism and anticonvulsant activity of milacemide in rats and mice. Colombo M; Strolin Benedetti M; Bonsignori A; Cocchiara G; Roncucci R; Dostert P J Neural Transm Suppl; 1990; 32():123-9. PubMed ID: 2089081 [TBL] [Abstract][Full Text] [Related]
9. A microdialysis study of glycinamide, glycine and other amino acid neurotransmitters in rat frontal cortex and hippocampus after the administration of milacemide, a glycine pro-drug. Doheny MH; Nagaki S; Patsalos PN Naunyn Schmiedebergs Arch Pharmacol; 1996 Jul; 354(2):157-63. PubMed ID: 8857592 [TBL] [Abstract][Full Text] [Related]
10. Milacemide effects on the temporal inter-relationship of amino acids and monoamine metabolites in rat cerebrospinal fluid. Semba J; Patsalos PN Eur J Pharmacol; 1993 Jan; 230(3):321-6. PubMed ID: 8440309 [TBL] [Abstract][Full Text] [Related]
11. Effects of the glycine prodrug milacemide (2-N-pentylaminoacetamide) on catecholamine secretion from isolated adrenal medulla chromaffin cells. Yadid G; Zinder O; Youdim MB Br J Pharmacol; 1991 Nov; 104(3):760-4. PubMed ID: 1797336 [TBL] [Abstract][Full Text] [Related]
12. Effect of milacemide on extracellular and tissue concentrations of dopamine and 5-hydroxytryptamine in rat frontal cortex. Semba J; Doheny M; Patsalos PN; Sarna G; Curzon G Br J Pharmacol; 1992 Jan; 105(1):59-62. PubMed ID: 1596690 [TBL] [Abstract][Full Text] [Related]
13. Determination of moclobemide in human plasma by high-performance liquid chromatography with spectrophotometric detection. Amini H; Shahmir B; Ahmadiani A J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Aug; 807(2):271-5. PubMed ID: 15203040 [TBL] [Abstract][Full Text] [Related]
14. The disposition of valproyl glycinamide and valproyl glycine in rats. Blotnik S; Bergman F; Bialer M Pharm Res; 1997 Jul; 14(7):873-8. PubMed ID: 9244143 [TBL] [Abstract][Full Text] [Related]
15. A high-performance liquid-chromatographic microanalytical procedure for the rapid estimation of piracetam in plasma or cerebrospinal fluid. Doheny MH; O'Connell MT; Patsalos PN J Pharm Pharmacol; 1996 May; 48(5):514-6. PubMed ID: 8799877 [TBL] [Abstract][Full Text] [Related]
16. Interactions of some analogues of the anticonvulsant milacemide with monoamine oxidase. O'Brien EM; Dostert P; Pevarello P; Tipton KF Biochem Pharmacol; 1994 Aug; 48(5):905-14. PubMed ID: 8093103 [TBL] [Abstract][Full Text] [Related]
17. Simple high-performance liquid chromatographic method for the measurement of toloxatone in rabbit cerebrospinal fluid and plasma. Vistelle R; Lamiable D; Zinzou M J Chromatogr; 1989 May; 490(2):387-94. PubMed ID: 2768411 [TBL] [Abstract][Full Text] [Related]
18. Species differences in the interactions of the anticonvulsant milacemide and some analogues with monoamine oxidase-B. O'Brien EM; Dostert P; Tipton KF Biochem Pharmacol; 1995 Jul; 50(3):317-24. PubMed ID: 7646533 [TBL] [Abstract][Full Text] [Related]
19. Milacemide, a glycine prodrug, enhances performance of learning tasks in normal and amnestic rodents. Handelmann GE; Nevins ME; Mueller LL; Arnolde SM; Cordi AA Pharmacol Biochem Behav; 1989 Dec; 34(4):823-8. PubMed ID: 2516327 [TBL] [Abstract][Full Text] [Related]
20. Liquid chromatography-tandem mass spectrometry for quantification of lacosamide, an antiepileptic drug, in rat plasma and its application to pharmacokinetic study. Kim SJ; Koo TS; Ha DJ; Baek M; Lee SK; Shin DS; Moon H Biomed Chromatogr; 2012 Mar; 26(3):371-6. PubMed ID: 21735462 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]